DUR BOARD QUARTERLY MEETING
Ameri-Tel Inn Board Room,
7965 W Emerald, Boise, Idaho
April 1, 2004
9:00 AM

1. 9:00 AM Approval of minutes from January meeting – R. Ting
2. 9:15 AM Follow-up Intervention reports from fourth quarter
   1. Migraine Headache Treatment and Prophylaxis – C. Owens
   2. Proton-Pump Inhibitor Use –T. Pettinger
   3. COX-2 Inhibitor Use –C. Owens
3. 9:45 AM Current interventions
   1. Off-label Gabapentin Use – C. Owens
   2. Appropriate Antibiotic Therapy for Strep Pharyngitis – T. Pettinger
   3. Appropriate Use of Palivizumab (Synagis®) – C. Owens
4. 11:15 AM Proposed interventions for first quarter 2004
   1. Carisoprodol Safety – C. Owens
   2. COX-2 Inhibitors and Hypertension – R. Force
   3. Stimulant & Strattera Usage – C. Owens
5. 11:45 AM DUR Newsletter – C. Owens
   1. Idaho DUR – V. Culbertson
   2. Tablet-splitting and cost savings
   3. COX-2 Inhibitors and HTN
   4. Cost Corner: COX-2 Inhibitors and NSAIDs

LUNCH

1. 1:00 PM Top 50 – C. Owens
2. 1:30 PM Medicaid update – T. Eide
3. 2:00 PM Other Business
   1. Conflict of Interest Statement –R. Force
   2. DUR Website Updates –C. Owens
   3. Annual Report –C. Owens
4. 3:00 PM Adjourn

Future Meeting dates: June 17, September 16, January 20, 2005